#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Heart disease congenital Cardiac failure acute Usher's syndrome Cerebral amyloid angiopathy Intracranial germ cell tumour Granulomatosis with polyangiitis Kidney transplant rejection Congenital megacolon Candida infection Depression Squamous cell carcinoma of the hypopharynx Pyoderma gangrenosum Autoinflammation with infantile enterocolitis NTRK gene fusion overexpression Advanced systemic mastocytosis More trials…

    Learn about Rare Diseases

    Breast angiosarcoma metastatic Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Focal segmental glomerulosclerosis Leiomyosarcoma – Basic Information Antisynthetase syndrome Glomerulonephritis membranoproliferative – Diagnostics Cystic fibrosis – Treatment Wiskott-Aldrich syndrome – Diagnostics Angelman’s syndrome – Diagnostics Combined immunodeficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Florbetapir (18F) Autologous Pancreatic Islets Rosuvastatin Zinc Ovolecithin Vilanterol Etranacogene Dezaparvovec Remifentanil Hydrochloride Magnesium Sulfate Colecalciferol Stx-241 Bi 1291583 Omp66 Alnus Glutinosa Pollen Pf-06835375 Benzathine Benzylpenicillin Gadoxetic Acid, Disodium NERANDOMILAST Chlorhexidine Gluconate Linaclotide Nelivaptan More therapies…

    Learn about Your Condition

    Pancreatic carcinoma Cardiac disorder Malignant melanoma of eyelid Radiation skin injury Febrile neutropenia Bronchiolitis Milk allergy Colon cancer stage III Post procedural hypotension Normal pressure hydrocephalus Autoimmune haemolytic anaemia Breast cancer stage II Compulsive sexual behaviour Bone hypertrophy Transient ischaemic attack More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Head and neck cancer metastatic

  • Comparing Two Treatment Lengths of Cetuximab, Avelumab, Cisplatin, and Docetaxel for Patients with Returning Spread Head and Neck Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer metastatic
    Investigated Drugs:
    • Avelumab
    • Carboplatin
    • Cetuximab
    Germany

  • Study of eftilagimod alpha with pembrolizumab combination therapy for patients with metastatic head and neck cancer who have not received previous treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer metastatic
    Investigated Drugs:
    • Eftilagimod Alfa
    • Pembrolizumab
    Belgium Denmark Germany Romania Spain

  • Study of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer metastatic
    • Head and neck cancer stage III
    • Head and neck cancer stage IV
    Investigated Drugs:
    • Tisotumab Vedotin
    • Carboplatin
    • Cisplatin
    France Germany Italy Spain

  • Study on the Safety and Effects of Durvalumab and Tremelimumab with Radiotherapy for Patients with Metastatic Squamous Cell Carcinoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Head and neck cancer metastatic
    • Lung squamous cell carcinoma metastatic
    • Metastatic squamous cell carcinoma
    Investigated Drugs:
    • Tremelimumab
    • Durvalumab
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!